Archive - March 2021
Is It Time to Assess the Mental Fitness of Our Presidents?
A Week’s Worth of Recalls
Fishawack Health acquires market access and HEOR consultancy PRMA Consulting
BMS and bluebird bio gain FDA approval for multiple myeloma therapy
EMA recommends new manufacturing sites for COVID-19 vaccines
Single Pfizer/BioNTech dose induces strong immune response to COVID-19
New research project aims to improve understanding of differing decisions on medicine use
Novartis UK signs digital partnership with Cievert for chronic disease management